Skin lightening composition
OwnerYoshinobu Morimoto, Asami Watakeinventors
Life of this patent
Estimating the term…
Abstract
A composition which comprises (i) tranexamic acid or a salt thereof, (ii) L-cysteine, a derivative thereof or a salt thereof and, as occasion demands, (iii) L-ascorbic acid, a derivative thereof or a salt thereof.
Claims15
A composition which comprises (i) tranexamic acid or a salt thereof and (ii) L-cysteine, a derivative thereof or a salt thereof.
A composition which comprises (i) 50 to 2,500 mg of tranexamic acid or a salt thereof and (ii) 30 to 750 mg of L-cysteine, a derivative thereof or a salt thereof, in terms of administrating amounts (doses) per day.
A composition which comprises tranexamic acid and L-cysteine.
A composition which comprises 50 to 2,500 mg of tranexamic acid and 30 to 750 mg of L-cysteine, in terms of administrating amounts (doses) per day.
A composition which comprises (i) tranexamic acid or a salt thereof, (ii) L-cysteine, a derivative thereof or a salt thereof and (iii) L-ascorbic acid, a derivative thereof or a salt thereof.
A composition which comprises (i) 50 to 2,500 mg of tranexamic acid or a salt thereof, (ii) 30 to 750 mg of L-cysteine, a derivative thereof or a salt thereof and (iii) 50 to 3,000 mg of L-ascorbic acid, a derivative thereof or a salt thereof, in terms of administrating amounts (doses) per day.
A composition which comprises tranexamic acid, L-cysteine and L-ascorbic acid.
A composition which comprises 50 to 2,500 mg of tranexamic acid, 30 to 750 mg of L-cysteine and 50 to 3,000 mg of L-ascorbic acid, in terms of administrating amounts (doses) per day.
A method of whitening, which comprises administering (i) tranexamic acid or a salt thereof and (ii) L-cysteine, a derivative thereof or a salt thereof.
A method for treating pigmentations, which comprises administering (i) tranexamic acid or a salt thereof and (ii) L-cysteine, a derivative thereof or a salt thereof.
A method of whitening, which comprises administering (i) tranexamic acid or a salt thereof, (ii) L-cysteine, a derivative thereof or a salt thereof and (iii) L-ascorbic acid, a derivative thereof or a salt thereof.
A method for treating pigmentations, which comprises administering (i) tranexamic acid or a salt thereof, (ii) L-cysteine, a derivative thereof or a salt thereof and (iii) L-ascorbic acid, a derivative thereof or a salt thereof.
Dependencies are inferred from the claim text.